(Q34050999)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008737%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

Chemoembolization for intermediate HCC: is there proof of survival benefit? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008737%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Chemoembolization for intermediate HCC: Is there proof of survival benefit? (English)

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.017

15 December 2024

main subject

hepatocellular carcinoma

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008737%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Josep M. Llovet

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008737%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Jordi Bruix

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008737%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1

Alejandro Forner

1 reference

30 July 2017

3

Jordi Bruix

1 reference

30 July 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22008737

15 December 2024

publication date

17 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008737%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

14 January 2020

https://doi.org/10.1016/j.jhep.2011.08.017

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22008737

https://api.elsevier.com/content/article/PII:S0168827811007331?httpAccept=text/xml

15 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.017

https://api.elsevier.com/content/article/PII:S0168827811007331?httpAccept=text/plain

15 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.017

15 December 2024

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008737%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008737%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008737%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

984-986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008737%20AND%20SRC:MED&resulttype=core&format=json

Design and endpoints of clinical trials in hepatocellular carcinoma.

14 January 2020

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.017

Management of hepatocellular carcinoma: An update

15 December 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.017

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

15 December 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.017

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

15 December 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.017

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

15 December 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.017

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

15 December 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.017

Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma

15 December 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.017

Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial

15 December 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.017

Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402).

15 December 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.017

A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma

15 December 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.017

Bile duct necrosis: complication of transcatheter hepatic arterial embolization

15 December 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.017

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

15 December 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.017